Selenium
Identification
- Summary
Selenium is an ingredient found in a variety of supplements and vitamins.
- Brand Names
- Nicomide
- Generic Name
- Selenium
- DrugBank Accession Number
- DB11135
- Background
Selenium is a trace metal in the human body particularly important as a component of glutathione peroxidase, an important enzyme in the prevention of cellular damage by free radicals and reactive oxygen species Label
- Type
- Small Molecule
- Groups
- Approved, Investigational, Vet approved
- Structure
- Weight
- Average: 78.96
Monoisotopic: 79.916521828 - Chemical Formula
- Se
- Synonyms
- Selen
- Selenio
- Sélénium
- Selenium elemental
- Selenium metallicum
- Selenium, elemental
- External IDs
- 231-957-4
- C.I. 77805
- CI 77805
Pharmacology
- Indication
For the supplementation of total parenteral nutrition to prevent hyposelenemia Label.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Selenium is incorporated into many different selenoproteins which serve various functions throughout the body 1.
- Mechanism of action
Selenium is first metabolized to selenophosphate and selenocysteine. Selenium incorporation is genetically encoded through the RNA sequence UGA 1. This sequence is recognized by RNA ste loop structures called selenocysteine inserting sequences (SECIS). These structures require the binding of SECIS binding proteins (SBP-2) to recognize selenocystiene. The specialized tRNA is first bound to a serine residue which is then enzymatically processed to a selylcysteyl-tRNA by selenocystiene sythase using selenophosphate as a selenium donor. Other unidentified proteins are required as part of the binding of this tRNA to the ribosome. Selenoproteins appear to be necessary for life as mice with the specialized tRNA gene knocked out exhibited early embryonic lethality 2.
The most important selenoproteins seem to be the glutathione peroxidases and thioredoxin reductases which are part of the body's defenses againts reactive oxygen species (ROS) 1. The importance of selenium in these anti-oxidant proteins has been implicated in the reduction of atherosclerosis by preventing the oxidation of low density lipoprotein 7 3. Selenium supplementation is also being investigated in the prevention of cancer and has been suggested to be beneficial to immune function 7 4 5.
- Absorption
Oral bioavailability of 90% when given as L-selenomethionine 8. Tmax of 9.17h.
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
Selenium supplements are typically available in the form of sodium selenite which is metabolized to selenide through either glutathione conjugation and subsequent reduction by glutathione reductase enzymes or reduction by thioredoxin reductases 1. Selenide is further metabolized to selenocystein by cysteine synthases and to selenophosphate by selenophosphate synthases. Selenide is also metabolized progressively to methyl-selenol, dimethyl selenide, then trimethylselenonium. Selenocysteine is degraded to methyl-selenol, pyruvate and ammonia by cysteine beta lyase. Selenocystein reacts with oxygen to form selenocysteine selenoxide which spontaneously degrades to methylselenic acid, pyruvate and ammonia. Methylselenic acid can be converted to methylselenol via conjugation with thiol groups on proteins like glutathione.
- Route of elimination
Mainly excreted in urine as 1beta-methylseleno-N-acetyl-d-galactosamine and trimethylselenonium 6. The amount excreted as 1beta-methylseleno-N-acetyl-d-galactosamine plateaus at doses around 2microg after which the amount excreted as trimethylselenonium increases. Some selenium is also excreted in feces when given orally 8.
- Half-life
Half life was observed to increase with chronic dosing time 8. For day 1-2 half life was 1.7 days. For day 2-3 half life was 3 days. For day 3-14 half life was 11.1 days.
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Oral LD50 of 6700mg/kg in rats MSDS. Selenium exposure is teratogenic and can result in fetal death as tested in mice. Chronic toxicity is characterized by hair loss, white horizontal streaking on fingernails, paronchyia, fatigue, irritability, hyperreflexia, nausea, vomiting, garlic odor on breath, and metallic taste Label. Serum selenium correlates weakly with symtoms. Blood chemistry as well as liver and kidney function are normally unnaffected. Acute toxicity presents as stupor, respiratory depression, and hypotension. ST elevations and t-wave changes characteristic of myocardial infarction may be observed.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbacavir Abacavir may decrease the excretion rate of Selenium which could result in a higher serum level. Aceclofenac Aceclofenac may decrease the excretion rate of Selenium which could result in a higher serum level. Acemetacin Acemetacin may decrease the excretion rate of Selenium which could result in a higher serum level. Acetaminophen Acetaminophen may decrease the excretion rate of Selenium which could result in a higher serum level. Acetazolamide Acetazolamide may increase the excretion rate of Selenium which could result in a lower serum level and potentially a reduction in efficacy. - Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- B-Traxim Se / Selsaf 2000
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Selenious Acid Injection, solution 60 ug/1mL Intravenous AMERICAN REGENT, INC. 2019-07-01 Not applicable US Selenious Acid Injection, solution 6 ug/1mL Intravenous AMERICAN REGENT, INC. 2022-03-28 Not applicable US Selenious Acid Injection, solution 40 ug/1mL Intravenous Woodward Pharma Services Llc 2022-03-15 Not applicable US - Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Bio Selenium Tab 50mcg Tablet 50 mcg / tab Oral SantÉ Naturelle (Ag) LtÉe 1988-12-31 2001-07-06 Canada Davinci Selenium Tab 50mcg Tablet 50 mcg / tab Oral Foodscience Laboratories, Division Of Foodscience Corporation 1988-12-31 1997-05-08 Canada Gnc Selenium 50mcg Tablet Tablet 50 mcg Oral General Nutrition Canada Inc. 1997-04-18 2005-08-05 Canada SELENASE® 50 MICROGRAMS/ML - ORAL SOLUTION Solution Oral IMEKS PHARMA SDN. BHD. 2020-09-08 Not applicable Malaysia Selenium Capsule 200 mcg / cap Oral Wampole Brands, A Division Of Pangeo Pharma (Canada) Inc. 2000-01-21 2002-07-29 Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 24 Multivitamins + Minerals Selenium (20 mcg) + Ascorbic acid (150 mg) + Beta carotene (10000 unit) + Biotin (25 mcg) + Calcium (130 mg) + Cholecalciferol (400 unit) + Choline bitartrate (25 mg) + Chromium (20 mcg) + Copper (1 mg) + Cyanocobalamin (25 mcg) + Ferrous fumarate (15 mg) + Folic acid (.8 mg) + Inositol (25 mg) + Magnesium (65 mg) + Manganese (2 mg) + Molybdenum (20 mcg) + Niacin (25 mg) + Calcium pantothenate (25 mg) + Potassium (15 mg) + Potassium Iodide (.1 mg) + Pyridoxine hydrochloride (25 mg) + Racemethionine (25 mg) + Riboflavin (25 mg) + Thiamine hydrochloride (25 mg) + Vanadium (20 mcg) + Vitamin A palmitate (5000 unit) + Vitamin E (50 unit) + Zinc (10 mg) Tablet Oral Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. 1997-04-30 2002-07-31 Canada 50 Plus Multiple Vitamins & Minerals Selenium (25 mcg) + Ascorbic acid (90 mg) + Biotin (45 mcg) + Calcium (200 mg) + Cholecalciferol (400 unit) + Chromium (10 mcg) + Copper (2 mg) + Cyanocobalamin (25 mcg) + Folic acid (0.4 mg) + Magnesium (100 mg) + Manganese (5 mg) + Molybdenum (25 mcg) + Nicotinamide (40 mg) + Pantothenic acid (10 mg) + Potassium Iodide (0.15 mg) + Pyridoxine hydrochloride (3 mg) + Riboflavin (3.2 mg) + Thiamine mononitrate (2.25 mg) + Vanadium (10 mcg) + Vitamin A palmitate (6000 unit) + Zinc (15 mg) Tablet Oral Gfr Pharma Ltd. 2002-10-20 2004-06-15 Canada A.C.E.S. Capsules Selenium (.025 mg / cap) + Ascorbic acid (250 mg / cap) + Beta carotene (10000 unit / cap) + Vitamin E (400 unit / cap) Capsule Oral Bioforce Canada Inc. 1994-12-31 1997-04-04 Canada A.R.T.H. Away Formula Selenium (1.54 mcg) + Calcium (24 mg) + Cholecalciferol (45 unit) + Copper (0.232 mg) + Folic acid (0.025 mg) + Manganese (0.58 mg) + Pyridoxine hydrochloride (0.5 mg) + Zinc (0.63 mg) Capsule Oral Abundance Naturally Ltd 1999-02-01 2006-06-16 Canada A/o-26 - Caplet Selenium (100 mcg) + Beta carotene (7500 unit) + Calcium (75 mg) + Calcium ascorbate (250 mg) + Copper (1 mg) + DL-alpha tocopheryl acetate (100 unit) + Folic acid (.4 mg) + Manganese (2.5 mg) + Racemethionine (50 mg) + Zinc (7.5 mg) Tablet Oral Enviro Tech International Canada 1996-12-19 1999-07-26 Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Folet DHA Selenium (65 ug/1) + Ascorbic acid (120 mg/1) + Beta carotene (2700 [iU]/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (12 ug/1) + D-alpha-Tocopherol acetate (18 [iU]/1) + Doconexent (350 mg/1) + Docusate sodium (50 mg/1) + Ferrous bisglycinate (38 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (30 mg/1) + Nicotinamide (20 mg/1) + Pyridoxine hydrochloride (40 mg/1) + Riboflavin (3.4 mg/1) + Thiamine hydrochloride (3 mg/1) + Zinc glycinate (10 mg/1) Capsule, liquid filled; Kit; Tablet Oral Pronova Corporation 2014-08-28 2017-03-15 US Foliflex Selenium (30 ug/1) + Ascorbic acid (250 mg/1) + Biotin (100 ug/1) + Boron (25 ug/1) + Calcium carbonate (75 mg/1) + Cholecalciferol (13.75 ug/1) + Chromium nicotinate (37.5 ug/1) + Cupric oxide (1 mg/1) + Cyanocobalamin (13 ug/1) + DL-alpha tocopheryl acetate (45 mg/1) + Ferrous fumarate (9 mg/1) + Folic acid (500 ug/1) + Magnesium oxide (37.5 mg/1) + Manganese sulfate (0.75 mg/1) + Molybdenum (25 ug/1) + Nicotinamide (22.5 mg/1) + Pantothenic acid (15 mg/1) + Potassium Iodide (25 ug/1) + Potassium chloride (24.5 mg/1) + Pyridoxine hydrochloride (6 mg/1) + Riboflavin (3.35 mg/1) + Thiamine mononitrate (3.25 mg/1) + Vitamin A acetate (1500 ug/1) + Zinc oxide (15 mg/1) Tablet Oral PureTek Corporation 2021-10-25 Not applicable US Folitin-Z Selenium (30 ug/1) + Ascorbic acid (250 mg/1) + Biotin (100 ug/1) + Boron (25 ug/1) + Calcium carbonate (75 mg/1) + Cholecalciferol (13.75 ug/1) + Chromium nicotinate (37.5 ug/1) + Cupric oxide (1 mg/1) + Cyanocobalamin (13 ug/1) + DL-alpha tocopheryl acetate (45 mg/1) + Ferrous fumarate (9 mg/1) + Folic acid (500 ug/1) + Magnesium oxide (37.5 mg/1) + Manganese sulfate (0.75 mg/1) + Molybdenum (25 ug/1) + Nicotinamide (22.5 mg/1) + Pantothenic acid (15 mg/1) + Potassium Iodide (25 ug/1) + Potassium chloride (24.5 mg/1) + Pyridoxine hydrochloride (6 mg/1) + Riboflavin (3.35 mg/1) + Thiamine mononitrate (3.25 mg/1) + Vitamin A acetate (1500 ug/1) + Zinc oxide (15 mg/1) Tablet Oral PureTek Corporation 2021-02-11 Not applicable US Keylosa Selenium (55 ug/1) + Ascorbic acid (120 mg/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (20 ug/1) + Chromium (35 ug/1) + Cyanocobalamin (8 ug/1) + Ferrous fumarate (27 mg/1) + Folic acid (1000 ug/1) + Magnesium oxide (200 mg/1) + Manganese sulfate (23 mg/1) + Molybdenum (45 ug/1) + Nicotinamide (20 mg/1) + Pyridoxine (20 mg/1) + Riboflavin (3.4 mg/1) + Thiamine mononitrate (3 mg/1) + Vitamin A (1500 ug/1) + Vitamin E (30 mg/1) + Zinc oxide (25 mg/1) Capsule, coated Oral Novian Pharmaceuticals 2023-10-06 Not applicable US Multitam Selenium (55 ug/1) + Ascorbic acid (120 mg/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (20 ug/1) + Chromium nicotinate (35 ug/1) + Cyanocobalamin (8 ug/1) + DL-alpha tocopheryl acetate (30 mg/1) + Folic acid (1000 ug/1) + Magnesium oxide (200 mg/1) + Manganese sulfate (2.3 mg/1) + Molybdenum (45 ug/1) + Nicotinamide (20 mg/1) + Pyridoxine hydrochloride (20 mg/1) + Riboflavin (3.4 mg/1) + Thiamine mononitrate (3 mg/1) + Vitamin A acetate (1500 ug/1) + Zinc oxide (25 mg/1) Tablet Oral PureTek Corporation 2022-01-17 Not applicable US
Categories
- Drug Categories
- Alimentary Tract and Metabolism
- Antioxidants
- Biological Factors
- Chalcogens
- Compounds used in a research, industrial, or household setting
- Diet, Food, and Nutrition
- Drugs that are Mainly Renally Excreted
- Elements
- Food
- Micronutrients
- Mineral Supplements
- Minerals
- Physiological Phenomena
- Polyvalent cation containing laxatives, antacids, oral supplements
- Protective Agents
- Selenium Compounds
- Trace Elements
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as homogeneous other non-metal compounds. These are inorganic non-metallic compounds in which the largest atom belongs to the class of 'other non-metals'.
- Kingdom
- Inorganic compounds
- Super Class
- Homogeneous non-metal compounds
- Class
- Homogeneous other non-metal compounds
- Sub Class
- Not Available
- Direct Parent
- Homogeneous other non-metal compounds
- Alternative Parents
- Not Available
- Substituents
- Homogeneous other non metal
- Molecular Framework
- Not Available
- External Descriptors
- nonmetal atom, chalcogen (CHEBI:27568)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- H6241UJ22B
- CAS number
- 7782-49-2
- InChI Key
- BUGBHKTXTAQXES-UHFFFAOYSA-N
- InChI
- InChI=1S/Se
- IUPAC Name
- selenium
- SMILES
- [Se]
References
- General References
- Ganther HE: Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 1999 Sep;20(9):1657-66. [Article]
- Brenneisen P, Steinbrenner H, Sies H: Selenium, oxidative stress, and health aspects. Mol Aspects Med. 2005 Aug-Oct;26(4-5):256-67. [Article]
- Zhang H, Luo Y, Zhang W, He Y, Dai S, Zhang R, Huang Y, Bernatchez P, Giordano FJ, Shadel G, Sessa WC, Min W: Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol. 2007 Mar;170(3):1108-20. [Article]
- Broome CS, McArdle F, Kyle JA, Andrews F, Lowe NM, Hart CA, Arthur JR, Jackson MJ: An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr. 2004 Jul;80(1):154-62. [Article]
- Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA Jr: Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005 Jan 19;97(2):94-102. [Article]
- Suzuki KT, Kurasaki K, Okazaki N, Ogra Y: Selenosugar and trimethylselenonium among urinary Se metabolites: dose- and age-related changes. Toxicol Appl Pharmacol. 2005 Aug 1;206(1):1-8. Epub 2004 Dec 8. [Article]
- Tinggi U: Selenium: its role as antioxidant in human health. Environ Health Prev Med. 2008 Mar;13(2):102-8. doi: 10.1007/s12199-007-0019-4. Epub 2008 Feb 28. [Article]
- Bugel S, Larsen EH, Sloth JJ, Flytlie K, Overvad K, Steenberg LC, Moesgaard S: Absorption, excretion, and retention of selenium from a high selenium yeast in men with a high intake of selenium. Food Nutr Res. 2008;52. doi: 10.3402/fnr.v52i0.1642. Epub 2008 Feb 12. [Article]
- External Links
- FDA label
- Download (150 KB)
- MSDS
- Download (110 KB)
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 4 Completed Prevention Anti Oxidative Stress / End Stage Renal Disease, Requiring Dialysis 1 4 Completed Prevention Cardiovascular Disease (CVD) / Chronic Obstructive Pulmonary Disease (COPD) 1 4 Completed Prevention Kidney Stones 1 4 Completed Treatment Peripartum Cardiomyopathy 1 4 Completed Treatment Statin Therapy 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution, concentrate Intravenous Tablet, film coated Oral Tablet, extended release Oral Capsule, liquid filled; kit; tablet Oral Tablet, delayed release Oral Tablet Oral Tablet Oral 50 mcg Powder Oral Capsule, gelatin coated Oral Liquid Oral Solution Intravenous Tablet Oral Capsule Oral Tablet, effervescent Oral Solution Parenteral 40.000 mcg Solution Intravenous; Oral 200 µg/5ml Injection, solution Intravenous Solution Oral Injection, solution Intravenous 40 ug/1mL Injection, solution Intravenous 6 ug/1mL Injection, solution Intravenous 60 ug/1mL Capsule Oral 200 mcg / cap Capsule Oral 100 mcg / cap Tablet Oral 200 mcg Capsule Oral Tablet Oral 50 mcg / tab Tablet, extended release Oral 50 mcg / tab Tablet Oral 200 mcg / tab Tablet Oral 100 mcg Capsule Oral 200 mcg Injection, solution Intramuscular; Intravenous 100 MCG Injection, solution Intramuscular; Intravenous 500 MCG Solution Oral 100 MCG Solution Oral 500 MCG Tablet, coated Oral Capsule, liquid filled Oral Powder, for solution Oral Capsule, coated Oral Kit Oral Tablet Oral 60 mcg - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) 217 MSDS boiling point (°C) 684.9 MSDS water solubility Insoluble MSDS logP 5 MSDS - Predicted Properties
Property Value Source logP 0.15 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 13.11 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 110.812 predictedDeepCCS 1.0 (2019) [M+H]+ 112.57921 predictedDeepCCS 1.0 (2019) [M+Na]+ 119.39906 predictedDeepCCS 1.0 (2019)
Enzymes
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- No
- Actions
- Substrate
- General Function
- Transferase activity
- Specific Function
- Catalyzes the decomposition of L-selenocysteine to L-alanine and elemental selenium.
- Gene Name
- SCLY
- Uniprot ID
- Q96I15
- Uniprot Name
- Selenocysteine lyase
- Molecular Weight
- 48148.45 Da
References
- Ganther HE: Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 1999 Sep;20(9):1657-66. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- No
- Actions
- Substrate
- General Function
- Nadp binding
- Specific Function
- Maintains high levels of reduced glutathione in the cytosol.
- Gene Name
- GSR
- Uniprot ID
- P00390
- Uniprot Name
- Glutathione reductase, mitochondrial
- Molecular Weight
- 56256.565 Da
References
- Ganther HE: Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 1999 Sep;20(9):1657-66. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- No
- Actions
- Substrate
- General Function
- Thioredoxin-disulfide reductase activity
- Specific Function
- Isoform 1 may possess glutaredoxin activity as well as thioredoxin reductase activity and induces actin and tubulin polymerization, leading to formation of cell membrane protrusions. Isoform 4 enha...
- Gene Name
- TXNRD1
- Uniprot ID
- Q16881
- Uniprot Name
- Thioredoxin reductase 1, cytoplasmic
- Molecular Weight
- 70905.58 Da
References
- Ganther HE: Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 1999 Sep;20(9):1657-66. [Article]
Drug created at December 03, 2015 16:51 / Updated at February 20, 2024 23:55